MedTrace Logo

A Study of Denosumab in Multiple Myeloma Patients With Renal Insufficiency

NCT02833610 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 55

Last updated 2026-02-18

No results posted yet for this study

Summary

This research study is studying a possible therapy as a possible treatment for the consequences of Multiple Myeloma with renal insufficiency.

Conditions

Interventions

DRUG

Denosumab Q4W

Sponsors & Collaborators

  • Amgen

    collaborator INDUSTRY

  • Emory University

    collaborator OTHER

  • University of Rochester

    collaborator OTHER

  • University Hospitals Cleveland Medical Center

    collaborator OTHER

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Elizabeth K O'Donnell, MD · Massachusetts General Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-31
Primary Completion
2023-03-20
Completion
2023-03-20
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02833610 on ClinicalTrials.gov